Literature DB >> 19282701

Diminished quality of life and physical function in community-dwelling elderly with anemia.

Mya Thein1, William B Ershler, Andrew S Artz, Josephine Tecson, Bruce E Robinson, Gerald Rothstein, Alexander Liede, Ina Gylys-Colwell, Z John Lu, Sean Robbins.   

Abstract

The occurrence of anemia in older adults has been associated with adverse outcomes including functional decline, disability, morbidity, and mortality. It is not clear to what extent these outcomes are the result of the anemia or concurrent illness. We performed a cross-sectional, observational study to determine whether lower hemoglobin concentrations in older adults are associated with reduced health-related quality of life, functional status, depression, disability, and physical strength, independent of chronic disease. Three sites participated in this research: an academic geriatric practice, a hospital-based geriatric outpatient unit, and a community-based multispecialty internal medicine group. Health-related quality of life and functional status were measured using the Short Form-36 Health Survey (SF-36) and the Functional Assessment of Chronic Illness Therapy-Anemia (FACIT-An). Disability and depression were assessed using the Instrumental Activities of Daily Living (IADL) and the Geriatric Depression Scale (GDS) questionnaires, respectively. Handgrip strength was used as a physical performance measure. Anemia was defined as hemoglobin <13 g/dL for men or <12 g/dL for women. The mean SF-36 physical health component summary scores were 38.9 (with anemia) and 44.1 (without anemia) (p<0.001). Anemia was associated with greater fatigue (p < 0.001), lower handgrip strength (p = 0.014), increased number of disabilities (p=0.005), and more depressive symptoms (p = 0.002). Multivariate regression analysis, adjusted for demographic and clinical characteristics, demonstrated strong associations for reduced hemoglobin, even within the "normal" range, and poorer health-related quality of life across multiple domains. Thus, anemia was independently associated with clinically significant impairments in multiple domains of health-related quality of life, especially in measures of functional limitation. Mildly low hemoglobin levels, even when above the World Health Organization (WHO) anemia threshold, were associated with significant declines in quality of life among the elderly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282701      PMCID: PMC2893336          DOI: 10.1097/MD.0b013e31819d89d5

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  49 in total

1.  IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

Authors: 
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

3.  Hematopoietic stem cell aging: mechanism and consequence.

Authors:  Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  Exp Gerontol       Date:  2007-01-31       Impact factor: 4.032

4.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.

Authors:  Viktor Janzen; Randolf Forkert; Heather E Fleming; Yoriko Saito; Michael T Waring; David M Dombkowski; Tao Cheng; Ronald A DePinho; Norman E Sharpless; David T Scadden
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

5.  Low testosterone levels and the risk of anemia in older men and women.

Authors:  Luigi Ferrucci; Marcello Maggio; Stefania Bandinelli; Shehzad Basaria; Fulvio Lauretani; Alessandro Ble; Giorgio Valenti; William B Ershler; Jack M Guralnik; Dan L Longo
Journal:  Arch Intern Med       Date:  2006-07-10

6.  What constitutes normal hemoglobin concentration in community-dwelling disabled older women?

Authors:  Paulo H M Chaves; Qian-Li Xue; Jack M Guralnik; Luigi Ferrucci; Stefano Volpato; Linda P Fried
Journal:  J Am Geriatr Soc       Date:  2004-11       Impact factor: 5.562

7.  Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.

Authors:  Justin A Ezekowitz; Finlay A McAlister; Paul W Armstrong
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

8.  Prevalence of anemia in skilled-nursing home residents.

Authors:  Andrew S Artz; Dean Fergusson; Paul J Drinka; Melvin Gerald; Stefan Gravenstein; Anthony Lechich; Felix Silverstone; Shanda Finnigan; Mark C Janowski; Mark A McCamish; William B Ershler
Journal:  Arch Gerontol Geriatr       Date:  2004 Nov-Dec       Impact factor: 3.250

9.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

10.  Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.

Authors:  Parag Agnihotri; Margaret Telfer; Zeeshan Butt; Abhay Jella; David Cella; Chris M Kozma; Mukesh Ahuja; Shahbaz Riaz; Joseph Akamah
Journal:  J Am Geriatr Soc       Date:  2007-08-14       Impact factor: 5.562

View more
  33 in total

1.  Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Authors:  George A Kaysen; Brett Larive; Patricia Painter; Alexander Craig; Robert M Lindsay; Michael V Rocco; John T Daugirdas; Gerald Schulman; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

2.  Anemia in frailty.

Authors:  Cindy N Roy
Journal:  Clin Geriatr Med       Date:  2011-02       Impact factor: 3.076

3.  A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.

Authors:  Elizabeth Price; Andrew S Artz; Huiman Barnhart; Shelly Sapp; Gordon Chelune; William B Ershler; Jeremy D Walston; Victor R Gordeuk; Nathan A Berger; David Reuben; Josef Prchal; Sunil V Rao; Cindy N Roy; Mark A Supiano; Stanley L Schrier; Harvey Jay Cohen
Journal:  Blood Cells Mol Dis       Date:  2014-07-25       Impact factor: 3.039

4.  Factors affecting health-related quality of life in Thai children with thalassemia.

Authors:  Montarat Thavorncharoensap; Kitti Torcharus; Issarang Nuchprayoon; Arthorn Riewpaiboon; Kaemthong Indaratna; Bang-On Ubol
Journal:  BMC Blood Disord       Date:  2010-01-21

Review 5.  Not so benign haematology: anaemia of the elderly.

Authors:  Akil A Merchant; Cindy N Roy
Journal:  Br J Haematol       Date:  2011-11-03       Impact factor: 6.998

6.  Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes.

Authors:  Zachary Gowanlock; Swetha Sriram; Alison Martin; Anargyros Xenocostas; Alejandro Lazo-Langner
Journal:  Blood Adv       Date:  2017-08-17

7.  Tongue exercise and ageing effects on morphological and biochemical properties of the posterior digastric and temporalis muscles in a Fischer 344 Brown Norway rat model.

Authors:  Brittany N Krekeler; Glen Leverson; Nadine P Connor
Journal:  Arch Oral Biol       Date:  2018-02-08       Impact factor: 2.633

Review 8.  Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review.

Authors:  Helen Gaskell; Sheena Derry; R Andrew Moore
Journal:  BMC Geriatr       Date:  2010-09-29       Impact factor: 3.921

9.  A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.

Authors:  Nabeel Khan; Dhruvan Patel; Yash Shah; Yu-Xiao Yang
Journal:  Dig Dis Sci       Date:  2017-03-11       Impact factor: 3.199

10.  A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE.

Authors:  Simon D Roger; Sarbjit V Jassal; Michael C Woodward; Steven Soroka; Lawrence P McMahon
Journal:  Int Urol Nephrol       Date:  2013-08-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.